Charles River Laboratories International (CRL) Short term Debt (2009 - 2022)

Charles River Laboratories International (CRL) has reported Short term Debt for 14 consecutive years, with $2.1 million the latest figure, recorded in Q3 2022.

• In Q3 2022, Short term Debt fell 8.62% year-over-year to $2.1 million; the TTM figure through Sep 2022 stood at $2.1 million (down 8.62% YoY), while the FY2021 annual figure was $2.8 million, down 94.43% from the prior year.
• Short term Debt came in at $2.1 million for Q3 2022 at Charles River Laboratories International, down from $2.4 million in the prior quarter.
• The five-year high for Short term Debt was $53.7 million in Q2 2020, with the low at $2.1 million in Q3 2022.
• Average Short term Debt over 5 years is $22.4 million, with a median of $31.0 million recorded in 2018.
• Across the five-year window, Short term Debt jumped 877.21% in 2019 and sank 94.43% in 2021, its largest moves.
• Year by year, Short term Debt stood at $31.4 million in 2018, then climbed by 22.69% to $38.5 million in 2019, then surged by 30.27% to $50.2 million in 2020, then tumbled by 94.43% to $2.8 million in 2021, then dropped by 25.62% to $2.1 million in 2022.
• According to Business Quant data, Short term Debt over the past three periods registered $2.1 million, $2.4 million, and $2.6 million for Q3 2022, Q2 2022, and Q1 2022 respectively.